Progress in the treatment of elderly patients with patent foramen ovale complicated with cryptogenic stroke
OU Wei-guang1
DENG Shao-dong2
CHEN Jian-ying3
1.Department of Structural Heart Disease,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,China;Guangdong Medical University,Zhanjiang 524000,China2.Guangdong Medical University,Zhanjiang 524000,China3.Department of Structural Heart Disease,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,China
摘要：Background The incidence of cryptogenic stroke(CS)accounts for about 25％of ischemic stroke.Current studies have shown that cryptogenic stroke is closely related to patent foramen ovale(PFO).Evaluating the correla-tion between PFO and CS needs to be combined with multidisciplinary evaluation.Many clinical studies have shown that drug therapy can reduce the risk of ischemic stroke in elderly PFO patients(＞60 years old).However,whether elderly PFO patients(＞60 years old)can benefit from PFO closure is still controversial.This article re-viewed the research progress of drug therapy and PFO closure therapy for cryptogenic stroke associated with PFO in the elderly.[S Chin J Cardiol 2024;25(1):50-56]
机标关键词：strokewithcomplicatedcryptogenicelderlyforamenovalepatent
论文发表日期：2024-03-30
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：7( 50-56 )
英文信息